Candidal infection in the central nervous system.

Area of Science:

• Mycology
• Neurology
• Infectious Diseases

Background:

• Candida species are a leading cause of cerebral mycosis, often identified post-mortem.
• Systemic candidiasis frequently involves the central nervous system (CNS), with high mortality rates.
• Immunosuppression is a significant risk factor for both systemic and CNS candidal infections.

Purpose of the Study:

• To highlight the prevalence and diagnostic challenges of CNS candidiasis.
• To identify key clinical correlations and neuropathological findings associated with Candida brain infections.
• To emphasize the need for earlier diagnosis to improve therapeutic efficacy.

Main Methods:

• Retrospective analysis of 29 patients with systemic candidiasis.
• Review of neuropathological findings, including cerebrospinal fluid examinations.
• Correlation of cardiac and cerebral involvement in candidiasis.

Main Results:

• 48% of patients with systemic candidiasis had CNS involvement.
• Only 21% of CNS candidiasis cases were diagnosed antemortem, with a low survival rate.
• A strong correlation (80%) was observed between cardiac and CNS candidal infections.
• New neuropathological lesions, including fungus balls and mycotic aneurysms, were identified.

Conclusions:

• Central nervous system candidiasis is underdiagnosed, contributing to high mortality.
• The link between cardiac and cerebral candidiasis serves as a diagnostic clue.
• Earlier detection of parenchymal Candida infections is essential for effective treatment with agents like amphotericin B.